As antibody tests for COVID-19 hit the market, “serology” has become a buzzword. Serologic testing can’t yet tell if individuals are immune to the SARS-CoV-2 virus. But population testing, by quantifying the number of people who have had an antibody response to infection, can help determine whether to maintain or relax strict public health measures on the way toward protective herd immunity. Watch this video to learn more.
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
You currently have no searches saved.
You currently have no courses saved.